A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older

Clinical trial NCT06961721 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06961721
Sponsor: Changchun BCHT Biotechnology Co.
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Prevention of Herpes Zoster

Start date: 2025-05-01
Primary completion: 2025-07-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.